Praxbind 2.5gm/50ml Solution For Injection belongs to the group of medicines called anticoagulant reversal agents used during a medical emergency to treat severe or uncontrolled bleeding that has been caused by taking dabigatran (a medicine used to prevent blood clots).

Praxbind 2.5gm/50ml Solution For Injection contains Idarucizumab, a humanised monoclonal antibody fragment (Fab) which rapidly traps dabigatran in order to inactivate its effect.

Praxbind 2.5gm/50ml Solution For Injection will be administered by a healthcare professional; do not self-administer. In some cases, Praxbind 2.5gm/50ml Solution For Injection may cause headaches, constipation, fever, low potassium levels, and confusion. Do not be reluctant to talk with your doctor if any of the side effects persist or worsen.

Consult the doctor if you are pregnant or breastfeeding. The safety and effectiveness of Praxbind 2.5gm/50ml Solution For Injection in children have not been established. Keep the doctor informed about your health condition and medications to rule out any side effects/interactions.

Praxbind 2.5gm/50ml Solution For Injection belongs to the group of medicines called anticoagulant reversal agents indicated in patients treated with dabigatran (a medicine used to prevent blood clots) when reversal of the anticoagulant effects of dabigatran is needed for emergency surgery/urgent procedures, in life-threatening conditions or uncontrolled bleeding. Praxbind 2.5gm/50ml Solution For Injection contains Idarucizumab, a humanised monoclonal antibody fragment (Fab) which rapidly traps dabigatran in order to inactivate its effect.

• Headache
• Constipation
• Fever
• Hypokalaemia (low potassium levels)
• Confusion

Inform the doctor if you are allergic to any of the components in Praxbind 2.5gm/50ml Solution For Injection, if you have hereditary fructose intolerance or if you are on a sodium-restricted diet. Consult the doctor if you are pregnant or breastfeeding. Let the doctor know if you are taking any other medicines, including supplements and herbal products.

Drug-Drug Interactions: Inform the doctor if you are taking monoclonal antibodies (rozanolixizumab, efgartigimod alfa).

Drug-Food Interactions: No interactions found.

Drug-Disease Interactions: Inform the doctor if you have fructose intolerance or liver impairment.

• ROZANOLIXIZUMAB
• EFGARTIGIMOD ALFA

• Eat a healthy diet and exercise regularly to maintain proper weight.
• Avoid smoking and alcohol consumption.
• Avoid fast food, fried food, processed meats, refined carbs and added sugar.
• Get optimal sleep; rest well.

Bleeding: Bleeding is the loss of blood inside or outside the body. It is the main risk associated with dabigatran treatment. Severe or uncontrolled bleeding requires immediate medical attention to prevent loss of blood. Anticoagulant reversal agents such as Praxbind 2.5gm/50ml Solution For Injection are used to treat severe and uncontrolled bleeding.